Literature DB >> 11077584

["Field cancerization"--an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms].

M Aivado1, M Gynes, V Gorelov, W U Schmidt, H D Röher, P E Goretzki.   

Abstract

INTRODUCTION: The c-K-ras2-gene (K-ras) encodes the p21ras protein, which participates in the transduction of mitogenic signals from the cell surface to the nucleus. About 40-50% of colorectal cancers bear a point mutation of the K-ras codon 12 within exon I, leading to activation of the K-ras oncogene.
METHODS: Using a polymerase chain reaction (PCR)-based two-step restriction fragment length polymorphism (2sRFLP)-technique, we assessed the frequency of point mutations in the first or second base of K-ras codon 12 in patients suffering from colorectal carcinoma, adenoma, and their normal colon mucosa, respectively.
RESULTS: Similar to other investigators, we found mutations in 7 out of 17 (41%) colorectal carcinomas and 1 out of 4 (25%) adenomas. Using this very sensitive 2sRFLP technique (detection level = 0.2% of mutated cells), we were able to find K-ras codon 12 mutations in normal mucosa in 4 out of 18 (22.2%) patients with colorectal neoplasia.
CONCLUSIONS: This result can be explained by the phenomenon of "field cancerization" or by a local micrometastasis of K-ras-positive tumor cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11077584     DOI: 10.1007/s001040051207

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  9 in total

1.  [PET-CT studies of metastasizing cancer of the colon and rectum. Variability of tumor aggressiveness as a micro-evolutionary process of cancer stem cells with predetermined prognosis].

Authors:  F Stelzner; D von Mallek; J Ruhlmann; H J Biersack
Journal:  Chirurg       Date:  2009-07       Impact factor: 0.955

2.  [Autoregulatory growth control of adenomatous polyps and carcinogenesis in the colorectal region. Basics of tumor surgery Part I].

Authors:  F Stelzner
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

Review 3.  Stem cell dynamics in homeostasis and cancer of the intestine.

Authors:  Louis Vermeulen; Hugo J Snippert
Journal:  Nat Rev Cancer       Date:  2014-06-12       Impact factor: 60.716

4.  Genome-wide copy number changes and CD133 expression characterized distinct subset of colon polyps: differentiation between incidental polyps and cancer-associated polyps.

Authors:  Chih-Yung Yang; Ju-Yu Tseng; Chian-Feng Chen; Teh-Ying Chou; Hong-Wei Gao; Chia-Ling Hua; Chi-Hung Lin; Jen-Kou Lin; Jeng-Kai Jiang
Journal:  Int J Colorectal Dis       Date:  2015-07-24       Impact factor: 2.571

5.  Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity.

Authors:  Preetish Kadur Lakshminarasimha Murthy; Rui Xi; Diana Arguijo; Jeffrey I Everitt; Dewran D Kocak; Yoshihiko Kobayashi; Aline Bozec; Silvestre Vicent; Shengli Ding; Gregory E Crawford; David Hsu; Purushothama Rao Tata; Timothy Reddy; Xiling Shen
Journal:  Dev Cell       Date:  2022-02-07       Impact factor: 13.417

6.  [Regional growth preferences in hereditary, synchronous, and metachronous colorectal carcinomas. Basics of tumor surgery Part II].

Authors:  F Stelzner
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

7.  Clinicopathological differences of colorectal cancers according to tumor origin: Identification of possibly de novo lesions.

Authors:  Petros C Papagiorgis; Adamantia E Zizi; Sophia Tseleni; Ioannis N Oikonomakis; Nikolaos I Nikiteas
Journal:  Biomed Rep       Date:  2012-10-09

8.  Biased competition between Lgr5 intestinal stem cells driven by oncogenic mutation induces clonal expansion.

Authors:  Hugo J Snippert; Arnout G Schepers; Johan H van Es; Benjamin D Simons; Hans Clevers
Journal:  EMBO Rep       Date:  2013-12-15       Impact factor: 8.807

9.  Colorectal carcinogenesis: Review of human and experimental animal studies.

Authors:  Takuji Tanaka
Journal:  J Carcinog       Date:  2009
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.